SCHEMBL1727601

SCHEMBL1727601

O=c1n(-c2ccc(OCCNC3CCCCC3)cc2)ccn1-c1ccc(OC2CCCC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C19 P33261 1/20 0.52
ALDH1A1 P00352 6/20 0.49
HPGD P15428 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.44
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
FOXM1 Q08050 2/20 0.42
TDP1 Q9NUW8 1/20 0.41
XDH P47989 1/20 0.41
HRH3 Q9Y5N1 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6081508 0.96 KDM4E (0.50) KDM4ECYP1A2CYP2D6CYP2C19ALDH1A1
SCHEMBL1728644 0.87 HRH3 (0.42) KDM4ECYP1A2CYP2D6CYP2C19ALDH1A1
SCHEMBL1729303 0.86 ALDH1A1 (0.51) KDM4ECYP1A2CYP2D6CYP2C19ALDH1A1
SCHEMBL1727849 0.85 KDM4E (0.43) KDM4ECYP1A2CYP2D6CYP2C19ALDH1A1
SCHEMBL6081904 0.84 HRH3 (0.42) KDM4ECYP1A2CYP2D6CYP2C19ALDH1A1
SCHEMBL1729760 0.84 LSS (0.47) CYP1A2CYP2D6CYP2C19HRH3
SCHEMBL1729124 0.84 LSS (0.47) CYP1A2CYP2D6CYP2C19HRH3
SCHEMBL6081179 0.83 HRH3 (0.41) KDM4ECYP1A2CYP2D6CYP2C19ALDH1A1
SCHEMBL1728856 0.83 HRH3 (0.42) HRH3
SCHEMBL1728688 0.82 LSS (0.48) CYP1A2CYP2D6CYP2C19HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1551810-B1 DIARYL-SUBSTITUTED CYCLIC UREA DERIVATIVES HAVING AN MCH-MODULATORY EFFECT SANOFI AVENTIS DEUTSCHLAND (DE) 2011-11-30 EP disclosed
US-7141561-B2 Substituted diaryl heterocycles, process for their preparation and their use as medicaments SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-11-28 US disclosed